ANTIBODY Trademark

Trademark Overview


On Tuesday, March 29, 2022, a trademark application was filed for ANTIBODY with the United States Patent and Trademark Office. The USPTO has given the ANTIBODY trademark a serial number of 97337031. The federal status of this trademark filing is REGISTERED as of Tuesday, August 22, 2023. This trademark is owned by Antibody Biopharm Inc.. The ANTIBODY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services in the field of antibodies
antibody

General Information


Serial Number97337031
Word MarkANTIBODY
Filing DateTuesday, March 29, 2022
Status700 - REGISTERED
Status DateTuesday, August 22, 2023
Registration Number7147060
Registration DateTuesday, August 22, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 14, 2023

Trademark Statements


Description of MarkThe mark consists of three Y shaped structures in blue with a blue line below and three aqua blue circles above.  Below are Chinese characters and the wording ANTIBODY in red.
Indication of Colors claimedThe color(s) blue, red, and aqua blue is/are claimed as a feature of the mark.
Transliteration StatementThe non-Latin characters in the mark transliterate to "Chang Yuan Fu Neng" and this means "long source empower" in English.
Disclaimer with Predetermined Text"ANTIBODY"
Goods and ServicesResearch and development services in the field of antibodies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 4, 2022
Primary Code042
First Use Anywhere DateSaturday, January 1, 2022
First Use In Commerce DateSaturday, January 1, 2022

Trademark Owner History


Party NameAntibody Biopharm Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressClarksville, MD 21029

Party NameAntibody Biopharm Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressClarksville, MD 21029

Party NameAntibody Biopharm Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressClarksville, MD 21029

Trademark Events


Event DateEvent Description
Tuesday, August 22, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 22, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, July 19, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 18, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 7, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 7, 2023NON-FINAL ACTION E-MAILED
Friday, July 7, 2023SU - NON-FINAL ACTION - WRITTEN
Thursday, June 29, 2023STATEMENT OF USE PROCESSING COMPLETE
Saturday, June 3, 2023USE AMENDMENT FILED
Thursday, June 29, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, June 3, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, May 9, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 31, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 13, 2023NON-FINAL ACTION E-MAILED
Friday, January 13, 2023NON-FINAL ACTION WRITTEN
Thursday, January 12, 2023ASSIGNED TO EXAMINER
Tuesday, April 5, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, April 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 1, 2022NEW APPLICATION ENTERED